ScienceDex / Researcher record
Robbie G. Majzner
- Children's Hospital of Philadelphia · Pediatrics (investigator's affiliation)
- Dana-Farber Cancer Institute (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #3,367
- Program Leader
- Multi-Institutional
- Early Career
- Diverse Portfolio
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,715,595 | 4 | #3,146 |
| 2025 | $2,477,361 | 4 | #4,710 |
| 2026 | $4,528,990 | 5 | #3,367 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20244 records
- FY20254 records
- FY2026 · selected5 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14980986Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-6969-8011Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Pathology
FY2026 award records by amount
NIH award records listing Robbie G. Majzner as a PI. Multi-PI records show the full award amount for context.
- 5P01CA217959-08P01Contact PIDiscovering and Exploiting Mechanisms of Neuroblastoma Therapy ResistanceChildren's Hospital of Philadelphia · Pediatrics (investigator's affiliation)$2.5Maward amount
- 5U01CA281840-04U01Contact PIImmunotherapeutic targeting of gangliosides in Ewing Sarcoma$795.2Kaward amount
- $581.7Kaward amount
- 5R61AG090394-02R61Co-investigatorEngineered T cell approaches for Alzheimer's diseaseWashington University in St. Louis · Pathology (NIH department code)$543.3Kaward amount
- 3R61AG090394-02S1R61Co-investigatorEngineered T cell approaches for Alzheimer's diseaseWashington University in St. Louis · Pathology (NIH department code)$158.5Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Robbie G. Majzner as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardChildren's Hospital of Philadelphia
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3146
- 2024Entered Top 25% NationallyRanked #3146
- 2025$5M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 3 institutions
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Robbie G. Majzner.
Ido Amit
Washington University in St. Louis
3
shared awards
John M Maris
Children's Hospital of Philadelphia
3
shared awards
Jonathan Kipnis
Washington University in St. Louis
3
shared awards
Julie R Park
Children's Hospital of Philadelphia
3
shared awards
Kimberly Stegmaier
Dana-Farber Cancer Institute
3
shared awards
Shahab Asgharzadeh
Children's Hospital of Philadelphia
3
shared awards
Yael P Mosse
Children's Hospital of Philadelphia
3
shared awards
Kimberly Stegmaier
Children's Hospital of Philadelphia
2
shared awards
William A Weiss
Children's Hospital of Philadelphia
1
shared award